ACE2-TMPRSS2 co-enhanced RT4 Cell Line (CAT#: VCeL-Wyb051)

  • Product Overview
  • ACE2-TMPRSS2 co-enhanced human bladder carcinoma cell
  • Quantity
  • 3-5×106 cells/ml
  • Target
  • SARS-CoV-2
  • Applications
  • Effective tools for studying COVID-19 drugs and vaccines.
  • Cell Type
  • ACE2 and TMPRSS2 Co-Enhanced Cell Line
  • Organism
  • RT4 cells
  • Growth Properties
  • Adherent
  • Fluid Renewal
  • 2 to 3 times / week
  • Form
  • Frozen Cryovial
  • Biosafety Level
  • 1
  • Alternative Names
  • ACE2-TMPRSS2 co-enhanced RT4 Cell Line
Related products

Online Inquiry For Research Use Only. We do not provide direct services or products for patients.

Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.


Inquiry Basket